Ngā hua rapu - Raffaella Faggioni

  • E whakaatu ana i te 1 - 14 hua o te 14
Whakamahine hua
  1. 1
    Leptin in the regulation of immunity, inflammation, and hematopoiesis

    Leptin in the regulation of immunity, inflammation, and hematopoiesis mā Giamila Fantuzzi, Raffaella Faggioni

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Leptin regulation of the immune response and the immunodeficiency of malnutrition<sup>1</sup>

    Leptin regulation of the immune response and the immunodeficiency of malnutrition<sup>1</sup> mā Raffaella Faggioni, Kenneth R. Feingold, Carl Grünfeld

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis

    Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis mā Britta Siegmund, Kelly C. Lear-Kaul, Raffaella Faggioni, Giamila Fantuzzi

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Reduced Leptin Levels in Starvation Increase Susceptibility to Endotoxic Shock

    Reduced Leptin Levels in Starvation Increase Susceptibility to Endotoxic Shock mā Raffaella Faggioni, Arthur H. Moser, Kenneth R. Feingold, Carl Grunfeld

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma

    A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma mā Dave Singh, Binita Kane, Néstor A. Molfino, Raffaella Faggioni, Lorin Roskos, Ashley Woodcock

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody

    Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody mā Jackie Cheng, Meina Liang, Miguel F. Carvalho, Natalie J. Tigue, Raffaella Faggioni, Lorin Roskos, Inna Vainshtein

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Leptin-deficient (<i>ob</i>/<i>ob</i>) mice are protected from T cell-mediated hepatotoxicity: Role of tumor necrosis factor α and IL-18

    Leptin-deficient (<i>ob</i>/<i>ob</i>) mice are protected from T cell-mediated hepatotoxicity: Role of tumor necrosis factor α and IL-18 mā Raffaella Faggioni, Jessica Jones‐Carson, David Reed, Charles A. Dinarello, Kenneth R. Feingold, Carl Grünfeld, Giamila Fantuzzi

    I whakaputaina 2000
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    An open‐label, single‐dose bioavailability study of the pharmacokinetics of CAT‐354 after subcutaneous and intravenous administration in healthy males

    An open‐label, single‐dose bioavailability study of the pharmacokinetics of CAT‐354 after subcutaneous and intravenous administration in healthy males mā Chad K. Oh, Raffaella Faggioni, Feng Jin, Lorin Roskos, Bing Wang, Claire Birrell, Rosamund Wilson, Néstor A. Molfino

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Defective inflammatory response in interleukin 6-deficient mice.

    Defective inflammatory response in interleukin 6-deficient mice. mā Elena Fattori, Manuela Cappelletti, Paula Carvalho Costa, Carolina Sellitto, L Cantoni, Maria Carelli, Raffaella Faggioni, Giamila Fantuzzi, Pietro Ghezzi, Valeria Poli

    I whakaputaina 1994
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    WSX-1 Is Required for the Initiation of Th1 Responses and Resistance to L. major Infection

    WSX-1 Is Required for the Initiation of Th1 Responses and Resistance to L. major Infection mā Hiroki Yoshida, Shinjiro Hamano, Giorgio Senaldi, Todd Covey, Raffaella Faggioni, Sharon Mu, Min Xia, Andrew Wakeham, Hiroshi Nishina, Julia M. Potter, Chris Saris, Tak W. Mak

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma

    A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma mā Edward Piper, Christopher E. Brightling, Robert Niven, Chad K. Oh, Raffaella Faggioni, Kwai Poon, Dewei She, Chris Kell, Richard May, Gregory P. Geba, Néstor A. Molfino

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment

    Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment mā Maria Romano, Marina Sironi, Carlo Toniatti, Nadia Polentarutti, Paolo Fruscella, Pietro Ghezzi, Raffaella Faggioni, Walter Luini, Victor van Hinsbergh, Silvano Sozzani, Federico Bussolino, Valeria Poli, Gennaro Ciliberto, Alberto Mantovani

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    IL-18-Binding Protein Protects Against Lipopolysaccharide- Induced Lethality and Prevents the Development of Fas/Fas Ligand-Mediated Models of Liver Disease in Mice

    IL-18-Binding Protein Protects Against Lipopolysaccharide- Induced Lethality and Prevents the Development of Fas/Fas Ligand-Mediated Models of Liver Disease in Mice mā Raffaella Faggioni, Russell C. Cattley, Jane Guo, Silvia Flores, Heather Brown, Meiying Qi, Songmei Yin, David Hill, Sheila Scully, Ching Chen, David Brankow, Jeffrey Lewis, Claudia Baikalov, Harvey Yamane, Shi‐Yuan Meng, Frank Martin, Sylvia Hu, T. Boone, Giorgio Senaldi

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study

    Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study mā Bruce E. Sands, Jingjing Chen, Brian G. Feagan, Mark Penney, William A. Rees, Silvio Danese, Peter Higgins, Paul Newbold, Raffaella Faggioni, Kaushik Patra, Jing Li, Paul Klekotka, Chris Morehouse, Erik Pulkstenis, Jörn Drappa, René van der Merwe, Robert A. Gasser

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: